The Pan-American Journal of Ophthalmology (Jan 2023)

Central serous chorioretinopathy: Chance or casualty?

  • María Alejandra Martínez-Ceballos,
  • Laura Andrea Daza-Irreño,
  • Francisco J Rodríguez

DOI
https://doi.org/10.4103/pajo.pajo_67_23
Journal volume & issue
Vol. 5, no. 1
pp. 34 – 34

Abstract

Read online

We describe the clinical case of a man in the fifth decade of life with visual loss in his left eye without improvement since 2006, followed by a decreased visual acuity in 2017. The ophthalmic evaluation revealed bitemporal hemianopsia. A tumor in the pituitary gland was confirmed by a computed tomography scan and histopathological study. He was treated with systemic steroids and transsphenoidal resection. The patient improved his visual field, but his visual acuity remained decreased. Ophthalmological evaluation and imaging showed changes due to bilateral central serous chorioretinopathy (CSCR) with an acute process in the left eye during steroid systemic treatment. Reports suggest a possible association between the use of systemic corticosteroids and CSCR. Furthermore, the hormone-producing pituitary adenoma and retinal disease have been described. The ophthalmologist should consider the clinical backgrounds and risk factors associated with CSCR.

Keywords